- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | FY 2024 · Feb 3, 2024 | $1.18B |
| Total Assets | FY 2024 · Feb 3, 2024 | $5.36B |
| Current Assets | FY 2024 · Feb 3, 2024 | $951.74M |
| Cash And Equivalents | FY 2024 · Feb 3, 2024 | $125.43M |
| Total Liabilities | FY 2024 · Feb 3, 2024 | $4.18B |
| Long Term Debt | FY 2024 · Feb 3, 2024 | $1.58B |
| Current Liabilities | FY 2024 · Feb 3, 2024 | $1.11B |
| Operating Cash Flow | FY 2024 · Jan 28, 2023 | $346M |
| Sga Expense | FY 2024 · Jan 28, 2023 | $2.2B |
| Capex | FY 2024 · Jan 28, 2023 | $278.02M |
| Shares Diluted restated | FY 2024 · Jan 28, 2023 | 265.95M sh |
| Eps Basic | FY 2024 · Jan 28, 2023 | $0.34 |
| Revenue | FY 2024 · Jan 28, 2023 | $6.04B |
| Eps Diluted | FY 2024 · Jan 28, 2023 | $0.34 |
| Cost Of Revenue | FY 2024 · Jan 28, 2023 | $3.61B |
| Gross Profit | FY 2024 · Jan 28, 2023 | $2.43B |
| Operating Income | FY 2024 · Jan 28, 2023 | $225.56M |
| Net Income | FY 2024 · Jan 28, 2023 | $90.8M |